KR
KUBACKI RAYMOND C JR
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by KUBACKI RAYMOND C JR, Chairman & CEO. Officer active across 3 companies, notably PSYCHEMEDICS CORP. Cumulatively, 10 reports have been recorded. Activity tracked since 13 May 2021. The latest transaction was filed on 22 May 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
1,500 shares@ US$4.9310.7% of flowCommon Stock, $.005 Par ValueSEC:0001062993-23-012074:0
1,725 shares@ US$4.8712.1% of flowCommon Stock, $.005 Par ValueSEC:0001062993-23-011264:0
2,625 shares@ US$6.1824.9% of flowCommon Stock, $.005 Par ValueSEC:0001062993-22-022211:0
20,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-22-000022:0
1,725 shares@ US$6.440.073% mcap32.0% of flowCommon Stock, $.005 Par ValueSEC:0001843082-22-000010:0
3,062 shares@ US$8.500.16% mcap68.0% of flowCommon Stock, $.005 Par ValueSEC:0001843082-21-000028:0
3,062 shares@ US$8.50100.0% of flowCommon Stock, $.005 Par ValueSEC:0001843082-21-000028
23,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-21-000014
23,000 shares0Common Stock, $.005 Par ValueSEC:0001843082-21-000014:0
387,500 sharesCommon stock, par value $.001 per shareSEC:0001493152-16-007342:0
About KUBACKI RAYMOND C JR
Raymond C. Kubacki Jr. is the Chairman & CEO of Psychemedics Corp. He oversees the strategic direction of the company and is responsible for implementing growth initiatives. His leadership is essential for the development and success of Psychemedics.